Titre : Hypoglycémiants

Hypoglycémiants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Tissue Array Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypoglycémiants : Questions médicales les plus fréquentes", "headline": "Hypoglycémiants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypoglycémiants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-16", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypoglycémiants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Effets physiologiques des médicaments", "url": "https://questionsmedicales.fr/mesh/D045505", "about": { "@type": "MedicalCondition", "name": "Effets physiologiques des médicaments", "code": { "@type": "MedicalCode", "code": "D045505", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des glycoside hydrolases", "alternateName": "Glycoside Hydrolase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065089", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des glycoside hydrolases", "code": { "@type": "MedicalCode", "code": "D065089", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes des récepteurs de l'amyline", "alternateName": "Amylin Receptor Agonists", "url": "https://questionsmedicales.fr/mesh/D065091", "about": { "@type": "MedicalCondition", "name": "Agonistes des récepteurs de l'amyline", "code": { "@type": "MedicalCode", "code": "D065091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la dipeptidyl-peptidase IV", "alternateName": "Dipeptidyl-Peptidase IV Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054873", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la dipeptidyl-peptidase IV", "code": { "@type": "MedicalCode", "code": "D054873", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.500" } } }, { "@type": "MedicalWebPage", "name": "Secrétagogues à l'insuline", "alternateName": "Insulin Secretagogues", "url": "https://questionsmedicales.fr/mesh/D000092005", "about": { "@type": "MedicalCondition", "name": "Secrétagogues à l'insuline", "code": { "@type": "MedicalCode", "code": "D000092005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.625" } } }, { "@type": "MedicalWebPage", "name": "Agonistes du PPAR gamma", "alternateName": "PPAR-gamma Agonists", "url": "https://questionsmedicales.fr/mesh/D000092126", "about": { "@type": "MedicalCondition", "name": "Agonistes du PPAR gamma", "code": { "@type": "MedicalCode", "code": "D000092126", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.688" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cotransporteur sodium-glucose de type 2", "alternateName": "Sodium-Glucose Transporter 2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000077203", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cotransporteur sodium-glucose de type 2", "code": { "@type": "MedicalCode", "code": "D000077203", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.422.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Hypoglycémiants", "alternateName": "Hypoglycemic Agents", "code": { "@type": "MedicalCode", "code": "D007004", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nunzio Cardullo", "url": "https://questionsmedicales.fr/author/Nunzio%20Cardullo", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Giuseppe Floresta", "url": "https://questionsmedicales.fr/author/Giuseppe%20Floresta", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Vera Muccilli", "url": "https://questionsmedicales.fr/author/Vera%20Muccilli", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Antonio Rescifina", "url": "https://questionsmedicales.fr/author/Antonio%20Rescifina", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Corrado Tringali", "url": "https://questionsmedicales.fr/author/Corrado%20Tringali", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.", "datePublished": "2024-10-30", "url": "https://questionsmedicales.fr/article/39478631", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13014-024-02541-3" } }, { "@type": "ScholarlyArticle", "name": "EBV-Associated Gastric Cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.", "datePublished": "2024-04-01", "url": "https://questionsmedicales.fr/article/38685845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/aim.2024.28" } }, { "@type": "ScholarlyArticle", "name": "An Automation Workflow for High-Throughput Manufacturing and Analysis of Scaffold-Supported 3D Tissue Arrays.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37086259", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/adhm.202202422" } }, { "@type": "ScholarlyArticle", "name": "Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.", "datePublished": "2023-09-11", "url": "https://questionsmedicales.fr/article/37697694", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cjp2.342" } }, { "@type": "ScholarlyArticle", "name": "DNA quality evaluation of formalin-fixed paraffin-embedded heart tissue for DNA methylation array analysis.", "datePublished": "2023-02-03", "url": "https://questionsmedicales.fr/article/36737451", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-29120-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Hypoglycémiants", "item": "https://questionsmedicales.fr/mesh/D007004" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypoglycémiants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypoglycémiants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypoglycémiants", "description": "Comment diagnostiquer une hypoglycémie ?\nQuels tests sont utilisés pour le diabète ?\nQuels symptômes indiquent une hypoglycémie ?\nQuand consulter un médecin pour hypoglycémie ?\nQuel rôle joue l'HbA1c dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypoglycémiants", "description": "Quels sont les signes d'une hypoglycémie ?\nComment reconnaître une hypoglycémie sévère ?\nLes symptômes varient-ils selon les personnes ?\nQuels symptômes nécessitent une intervention rapide ?\nLes symptômes peuvent-ils être confondus avec d'autres ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypoglycémiants", "description": "Comment prévenir l'hypoglycémie ?\nQuel rôle joue l'exercice dans la prévention ?\nLes patients doivent-ils surveiller leur glycémie ?\nComment éduquer les patients sur l'hypoglycémie ?\nLes régimes alimentaires peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypoglycémiants", "description": "Quels sont les principaux hypoglycémiants ?\nComment administrer du glucose en cas d'hypoglycémie ?\nQuels sont les effets secondaires des hypoglycémiants ?\nComment ajuster le traitement hypoglycémiant ?\nLes hypoglycémiants sont-ils efficaces pour tous ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypoglycémiants", "description": "Quelles sont les complications de l'hypoglycémie ?\nL'hypoglycémie peut-elle entraîner des séquelles ?\nComment l'hypoglycémie affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme de l'hypoglycémie ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypoglycémiants", "description": "Quels sont les facteurs de risque d'hypoglycémie ?\nL'âge influence-t-il le risque d'hypoglycémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il aggraver l'hypoglycémie ?\nLes médicaments peuvent-ils influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Tissue+Array+Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une hypoglycémie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoglycémie est diagnostiquée par des tests de glycémie inférieure à 70 mg/dL." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diabète ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose." } }, { "@type": "Question", "name": "Quels symptômes indiquent une hypoglycémie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tremblements, sueurs, confusion et palpitations." } }, { "@type": "Question", "name": "Quand consulter un médecin pour hypoglycémie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes persistent ou s'aggravent." } }, { "@type": "Question", "name": "Quel rôle joue l'HbA1c dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'HbA1c évalue le contrôle glycémique sur 2-3 mois, utile pour le diagnostic du diabète." } }, { "@type": "Question", "name": "Quels sont les signes d'une hypoglycémie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue, irritabilité, faim intense et vertiges." } }, { "@type": "Question", "name": "Comment reconnaître une hypoglycémie sévère ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Une hypoglycémie sévère peut provoquer des convulsions, une perte de conscience ou un coma." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les personnes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier d'une personne à l'autre en fonction de la sensibilité." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une intervention rapide ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes graves comme confusion, convulsions ou perte de conscience nécessitent une aide immédiate." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être confondus avec ceux d'autres conditions comme l'anxiété ou l'AVC." } }, { "@type": "Question", "name": "Comment prévenir l'hypoglycémie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Prévenir l'hypoglycémie nécessite une alimentation équilibrée et un suivi régulier de la glycémie." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier aide à réguler la glycémie et à prévenir les épisodes d'hypoglycémie." } }, { "@type": "Question", "name": "Les patients doivent-ils surveiller leur glycémie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la surveillance régulière de la glycémie est essentielle pour prévenir l'hypoglycémie." } }, { "@type": "Question", "name": "Comment éduquer les patients sur l'hypoglycémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation doit inclure la reconnaissance des symptômes et les mesures à prendre en cas d'hypoglycémie." } }, { "@type": "Question", "name": "Les régimes alimentaires peuvent-ils aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime alimentaire équilibré et riche en fibres peut aider à stabiliser la glycémie." } }, { "@type": "Question", "name": "Quels sont les principaux hypoglycémiants ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux hypoglycémiants incluent la metformine, les sulfonylurées et les inhibiteurs DPP-4." } }, { "@type": "Question", "name": "Comment administrer du glucose en cas d'hypoglycémie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le glucose peut être administré par voie orale ou intraveineuse selon la gravité." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des hypoglycémiants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des diarrhées et des hypoglycémies." } }, { "@type": "Question", "name": "Comment ajuster le traitement hypoglycémiant ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement doit être ajusté en fonction des niveaux de glycémie et des symptômes." } }, { "@type": "Question", "name": "Les hypoglycémiants sont-ils efficaces pour tous ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité peut varier selon le type de diabète et la réponse individuelle." } }, { "@type": "Question", "name": "Quelles sont les complications de l'hypoglycémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des accidents vasculaires cérébraux et des chutes." } }, { "@type": "Question", "name": "L'hypoglycémie peut-elle entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des épisodes répétés peuvent causer des dommages neurologiques permanents." } }, { "@type": "Question", "name": "Comment l'hypoglycémie affecte-t-elle la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoglycémie fréquente peut entraîner une anxiété accrue et une diminution de la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles si l'hypoglycémie est traitée rapidement." } }, { "@type": "Question", "name": "Quels sont les risques à long terme de l'hypoglycémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques à long terme incluent des troubles cognitifs et une augmentation du risque cardiovasculaire." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'hypoglycémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent un traitement intensif du diabète, une alimentation irrégulière et l'alcool." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hypoglycémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de souffrir d'hypoglycémie en raison de la sensibilité accrue." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de diabète peuvent augmenter le risque d'hypoglycémie." } }, { "@type": "Question", "name": "Le stress peut-il aggraver l'hypoglycémie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affecter la glycémie et augmenter le risque d'hypoglycémie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments, comme les bêta-bloquants, peuvent masquer les symptômes d'hypoglycémie." } } ] } ] }

Sources (10000 au total)

Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.

Head and neck squamous cell carcinoma (HNSCC) negative for Human Papillomavirus (HPV) has remained a difficult to treat entity, whereas tumors positive for HPV are characterized by radiosensitivity an... A tissue microarray of a single center HNSCC cohort was stained for ATM, DNA-PKcs and Ku80 and the expression scored based on staining intensity and the percentages of tumor cells stained. Scores were... Samples from 427 HNSCC patients yielded interpretable stainings and were scored following an established algorithm. The majority of tumors showed strong expression of both NHEJ factors, whereas the ex... Our data suggest that HPV-negative HNSCC with particularly low Ku80 expression represent a highly radiosensitive subpopulation. Confirmation in independent cohorts is required....

EBV-Associated Gastric Cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.

Gastric cancer is the fourth leading cause of cancer-related deaths in the world. The identification of gastric cancer subtypes related to recognizable microbial agents may play a pivotal role in the ... Paraffin blocks of 682 cases of various types of gastric cancer from Tehran, South and North areas of Iran were collected. Twelve tissue microarray (TMA) blocks were constructed from these blocks. Loc... Fourteen out of 682 cases (2.1%) of gastric adenocarcinoma were EBER-positive. EBER was positive in 8 out of 22 (36.4%) of medullary carcinomas and 6 out of 660 (0.9%) of non-medullary type, which was... EBV-associated gastric adenocarcinoma has a low prevalence in Iran. This finding can be due to epidemiologic differences in risk factors and exposures, and the low number of gastric medullary carcinom...

Topographic analysis of pancreatic cancer by TMA and digital spatial profiling reveals biological complexity with potential therapeutic implications.

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human malignancies. Tissue microarrays (TMA) are an established method of high throughput biomarker interrogation in tissues but ...

Automated Lung Cancer Segmentation in Tissue Micro Array Analysis Histopathological Images Using a Prototype of Computer-Assisted Diagnosis.

Lung cancer is a fatal disease that kills approximately 85% of those diagnosed with it. In recent years, advances in medical imaging have greatly improved the acquisition, storage, and visualization o... Develop a computer-aided diagnostic system to detect lung cancer early by segmenting tumor and non-tumor tissue on Tissue Micro Array Analysis (TMA) histopathological images.... The prototype computer-aided diagnostic system was developed to segment tumor areas, non-tumor areas, and fundus on TMA histopathological images.... The system achieved an average accuracy of 83.4% and an F-measurement of 84.4% in segmenting tumor and non-tumor tissue.... The computer-aided diagnostic system provides a second diagnostic opinion to specialists, allowing for more precise diagnoses and more appropriate treatments for lung cancer....